BillionToOne, Inc. (BLLN) vs Indivior Pharmaceuticals Inc (INDV)
A side-by-side comparison of BillionToOne, Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLLN
BillionToOne, Inc.
$100.80HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
INDV
Indivior Pharmaceuticals Inc
$35.76HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — BLLN vs INDV
growth of $100 · dividends reinvested · last 1yBLLN +0.1% (+0.1%/yr)INDV +12.3% (+12.3%/yr)INDV compounded faster over this window
BLLN INDV
BLLN vs INDV: by the numbers
- •BLLN is the larger company ($4.64B vs $4.46B market cap).
- •INDV trades at the lower trailing earnings multiple (12.82 vs 162.55 P/E), one valuation lens rather than an overall verdict.
- •INDV converts more revenue to profit (26.65% vs 8.43% net margin).
- •INDV pays a dividend (1.32% yield), while BLLN has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BLLN | INDV |
|---|---|---|
| P/E ratio | 162.55 | 12.82 |
| Forward P/E | 126.91 | 8.47 |
| P/S ratio | 11.67 | 3.35 |
| P/B ratio | 8.64 | N/A |
| EV / EBITDA | 76.11 | 8.91 |
| FCF yield | 0.72% | N/A |
Profitability
| Metric | BLLN | INDV |
|---|---|---|
| Gross margin | 71.27% | 83.86% |
| Operating margin | 10.90% | 21.39% |
| Net margin | 8.43% | 26.65% |
| ROE | 6.24% | N/A |
| ROIC | 6.39% | N/A |
Dividends
| Metric | BLLN | INDV |
|---|---|---|
| Dividend yield | N/A | 1.32% |
| Payout ratio | N/A | 17.03% |
Growth (annualized)
| Metric | BLLN | INDV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.88% |
| Total return CAGR (5Y) | N/A | 19.65% |
Frequently asked
- Which has the lower trailing P/E, BLLN or INDV?
- INDV has the lower trailing P/E: BLLN trades at 162.55 and INDV at 12.82. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Does BLLN or INDV pay a bigger dividend?
- INDV pays a dividend (1.32% yield), while BLLN has no payments in the available dividend history.
- Is BLLN or INDV more profitable?
- INDV runs the higher net margin — BLLN at 8.43% versus INDV at 26.65%.
Go deeper
Dig into the metrics
BillionToOne P/E ratioIndivior Pharmaceuticals P/E ratioIndivior Pharmaceuticals dividend yieldBillionToOne ROEIndivior Pharmaceuticals ROEBillionToOne operating marginIndivior Pharmaceuticals operating marginBillionToOne revenue growthIndivior Pharmaceuticals revenue growthBillionToOne free cash flowIndivior Pharmaceuticals free cash flow
BillionToOne & Indivior Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.